Innopharma gets FDA nod for epilepsy generic

FDA approves generic version of UCB's injectable Keppra

PISCATAWAY, N.J. — The Food and Drug Administration has approved a generic drug for epilepsy.

Innopharma announced the FDA approval of levetiracetam injection. The drug is a generic version of UCB's Keppra.

Innopharma has a licensing agreement with X-GEN Pharmaceuticals for marketing and distribution of the drug.

Recommended stories

Login or Register to post a comment.